| Stage | DK | % of rev | XOM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.1B | 100.00% | $113B | 100.00% | XOM ×27.69 |
| Gross profit | $365M | 8.93% | $36.2B | 32.01% | XOM +23.1pp |
| Operating income | $302M | 7.40% | $21.4B | 18.93% | XOM +11.5pp |
| Pre-tax income | $222M | 5.43% | $21.2B | 18.77% | XOM +13.3pp |
| Net income | $180M | 4.41% | $16.0B | 14.16% | XOM +9.8pp |
| Stage | DK | XOM | Gap · A − B |
|---|---|---|---|
| Revenue | $4.1B100.00% | $113B100.00% | XOM ×27.69 |
| Gross profit | 8.93%$365M | 32.01%$36.2B | XOM +23.1pp |
| Operating income | 7.40%$302M | 18.93%$21.4B | XOM +11.5pp |
| Pre-tax income | 5.43%$222M | 18.77%$21.2B | XOM +13.3pp |
| Net income |
| 4.41%$180M |
| 14.16%$16.0B |
| XOM +9.8pp |